ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 267461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 267461; 2) Community: the network communities that were significantly associated with the response to NSC 267461; 3) Molecule: the relationships between components within communities and NSC 267461; 4) MDR: the compounds that were significantly associated with the NSC 267461.

NSC Compound Enrichment Correlation
NSC 143093 Acetylkidamycin 0.00928777138079756 0.25391355
NSC 266046 Oxaliplatin 0.00928777138079756 0.53769579
NSC 281279 Platinum, aqua(1,2-cyclohexanediamine-N,N')(tetraoxoselenato(2-)-O)-, (SP-4-3)- 0.00928777138079769 0.55334937
NSC 405159 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, 4-oxo-.alpha.-phenyl-, oxime 0.00928777138079769 0.42339617
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.00928777138079769 0.67319731
NSC 749600 Null 0.00928777138079769 0.4730045
NSC 755442 Null 0.00928777138079769 0.15935757
NSC 100071 component of Halotex 0.0107933723273943 0.64440592
NSC 102810 D-ARABINOSE, 5-O-TRITYL-TRIBENZOATE 0.0107933723273943 0.54843232
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0107933723273943 -0.026446041
Total:101  Current:31    [First] [Prev] [Next] [Last]